Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
1.650
-0.040 (-2.37%)
At close: Aug 22, 2025, 4:00 PM
1.710
+0.060 (3.64%)
After-hours: Aug 22, 2025, 7:27 PM EDT
Mustang Bio Market Cap
Mustang Bio has a market cap or net worth of $11.94 million as of August 22, 2025. Its market cap has increased by 214.32% in one year.
Market Cap
11.94M
Enterprise Value
-712.77K
1-Year Change
214.32%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since August 22, 2017, Mustang Bio's market cap has decreased from $257.00M to $11.94M, a decrease of -95.35%. That is a compound annual growth rate of -31.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 11.90M | 40.00% |
| Dec 31, 2024 | 8.50M | -31.45% |
| Dec 29, 2023 | 12.40M | -70.75% |
| Dec 30, 2022 | 42.40M | -72.66% |
| Dec 31, 2021 | 155.10M | -37.18% |
| Dec 31, 2020 | 246.90M | 49.18% |
| Dec 31, 2019 | 165.50M | 106.36% |
| Dec 31, 2018 | 80.20M | -74.50% |
| Dec 29, 2017 | 314.50M | 22.37% |
| Aug 22, 2017 | 257.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |